Skip to main content
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma.
Physician Perspectives on Palliative Care for Children With Neuroblastoma: An International Context.
Improved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell Disease.
Extended Sedation With Continuous Midazolam or Dexmedetomidine Infusion for Young Children Receiving 131 I-MIBG Radiopharmaceutical Therapy for Advanced Neuroblastoma.
Evaluation and Outcome of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia in Dar es Salaam, Tanzania.
Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).
Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group.
Clinical features and outcomes of infants with Ewing sarcoma under 12 months of age.
Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.